Pfizer (PFE) shares fell 2.6% in Thursday trading after the company reaffirmed its fiscal 2026 guidance in a regulatory filing.
The company continues to expect fiscal 2026 adjusted earnings of $2.80 to $3.00 per diluted share and revenue range of $59.5 billion to $62.5 billion, according to the filing with the US Securities and Exchange Commission.
Analysts surveyed by FactSet expect $2.96 and $61.74 billion, respectively.
Price: $25.25, Change: $-0.67, Percent Change: -2.58%